文献速递乳腺癌支持与姑息治疗

基于结局信息支持乳腺癌根治术后监测共同决策:SHOUT-BC研究结果

Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study.
PubMed 文献 · Eur J Cancer · 2024-11-02

SHOUT-BC研究采用前瞻性多中心中断时间序列设计,在八家荷兰医院逐步实施乳腺癌监测决策辅助工具(BCS-PtDA),共507名参与者在首次监测咨询后完成问卷。实施后患者报告的共同决策显著增加(总体估计效应27.14,95%CI 22.71至31.87,p<.0001),决策冲突减少、知识增加、恐惧癌症复发下降,监测强度略有降低,BCS-PtDA获得高度积极评价。

要点

  • 实施BCS-PtDA后患者报告的共同决策显著增加,总体估计效应27.14(95%CI 22.71至31.87,p<.0001)。
  • 实施后参与者(n=225)报告更积极的决策角色、更低的决策冲突及更高的监测知识。
  • 实施后恐惧癌症复发下降,自我报告的监测方案强度略有降低,BCS-PtDA获高度积极评价。

核心结论

  • 实施整合结局信息的BCS-PtDA后,患者报告的共同决策增加,决策质量改善,参与者对BCS-PtDA评价高度积极。
  • 进一步研究应关注实施优化。

研究设计与样本

  • 前瞻性多中心中断时间序列(ITS)设计,将BCS-PtDA逐步实施到八家荷兰医院的诊疗路径中。
  • 共507名参与者在首次监测咨询后完成问卷,该咨询通常在术后约一年进行。

主要发现

  • 按医院进行ITS分析及后续对医院效应的Meta分析显示,实施前后患者报告的共同决策显著增加(总体估计效应27.14,95%CI 22.71至31.87,p<.0001)。
  • 实施后参与者(n=225)报告在决策中角色更积极、决策冲突减少、对监测目的和方法的了解增加。
  • 实施后观察到恐惧癌症复发(FCR)下降。
  • 自我报告的监测方案强度略有降低,BCS-PtDA获得高度积极的评价。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 进一步研究应关注实施优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Integrating outcome information into the process of shared decision-making (SDM) about post-treatment surveillance can enhance its effectiveness. The Breast Cancer Surveillance Decision Aid (BCS-PtDA) integrates risk estimations of patients' risks for recurrences as well as outcome information on fear of cancer recurrence (FCR). The SHOUT-BC study aimed to evaluate the effectiveness of the implementation of the BCS-PtDA. Patients' satisfaction with the BCS-PtDA was also evaluated. METHODS: As described in a previously published protocol paper, the study employed a Prospective multiple interrupted time series (ITS) design in which the BCS-PtDA was implemented stepwise into the care pathways of eight Dutch hospitals. RESULTS: A total of 507 participants completed a questionnaire after their first surveillance consultation which usually takes place approximately one year after surgery. ITS analysis per hospital and subsequent meta-analysis over hospital effects indicated a significant increase in patient-reported SDM from pre- to post-implementation (overall estimated effect: 27.14, 95 % CI: 22.71 to 31.87, p < .0001). Moreover, post-implementation participants (n = 225) reported a more active role in decision-making, decreased decisional conflict, and increased knowledge on the aim and methods of surveillance. Furthermore, a decrease in FCR was seen post-implementation. The self-reported intensity of surveillance schedules decreased slightly and the BCS-PtDA received highly positive evaluations. DISCUSSION: The implementation of the BCS-PtDA, which integrates outcome information, led to increased patient-reported SDM and an improved quality of decision-making. The BCS-PtDA was evaluated highly positively by participants. Further research should address optimisation of the implementation.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Ankersmid JW, Drossaert CHC, Strobbe LJA, et al. Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study. Eur J Cancer. 2024. PMID: 39504676. doi:10.1016/j.ejca.2024.115107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。